Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jul;65(7):2765-71.
doi: 10.1128/iai.65.7.2765-2771.1997.

Cloning and characterization of a Prevotella melaninogenica hemolysin

Affiliations

Cloning and characterization of a Prevotella melaninogenica hemolysin

H E Allison et al. Infect Immun. 1997 Jul.

Abstract

Hemolysins have been proven to be important virulence factors in many medically relevant pathogenic organisms. Their production has also been implicated in the etiology of periodontal disease. Hemolytic strain 361B of Prevotella melaninogenica, a putative etiologic agent of periodontal disease, was used in this study. The cloning, sequencing, and characterization of phyA, the structural gene for a P. melaninogenica hemolysin, is described. No extensive sequence homology could be identified between phyA and any reported sequence at either the nucleotide or amino acid level. As predicted from sequence analysis, this gene produces a 39-kDa protein which has hemolytic activity as measured by zymogram analysis. Unlike many Ca2+-dependent bacterial hemolysins, both the cloned and native PhyA proteins were enhanced by the presence of EDTA in a dose-dependent fashion with 40 mM EDTA allowing maximum activity. Ca2+ and Mg2+ were found to be inhibitory. The hemolytic activity also was found to have a dose-dependent endpoint. Through recovery of hemolytic activity from a spent reaction, this endpoint was shown to be the result of end product inhibition. This is the first report describing the cloning and sequencing of a gene from P. melaninogenica.

PubMed Disclaimer

References

    1. Infect Immun. 1987 Mar;55(3):810-5 - PubMed
    1. J Bacteriol. 1960 Aug;80:164-70 - PubMed
    1. Scand J Infect Dis Suppl. 1989;62:15-24 - PubMed
    1. Oral Microbiol Immunol. 1989 Mar;4(1):12-8 - PubMed
    1. J Clin Microbiol. 1990 Mar;28(3):422-5 - PubMed

Publication types

Substances

Associated data